Posted by Ken Crites & Laura Bowe on Aug 28, 2018
It's that time again -- time to support LIGHT THE NIGHT and their fight against Leukemia and Lymphoma!
Donate via the Burlington Sunrise Rotary team by going here.  This year the official donate team is made up of Laura B., Steve G., Gail D. and Bobby I. and Jesse R.  A big THANK YOU to Laura and Steve for again leading our efforts!
This year's actual Light The Night event is September 28th, 2018.
Ever wonder what impact the Leukemia & Lymphoma Society is having in our area?  Well, here are those details:
And here are more questions and answers from LLS:
What is Light The Night?
Light The Night (LTN) is LLS’s annual fundraising walk where friends, families and co-workers form fundraising teams and millions of consumers help by donating at retail outlets. These efforts culminate in inspirational, memorable evening walks in nearly 150 communities each fall across North America. Participants carry illuminated lanterns – white for survivors, red for supporters and gold lanterns in memory of loved ones lost.  Locally, the Upstate New York/Vermont Chapter has three walks: in Burlington, Vermont at Edmunds School Gym on Friday, September 28 and at Siena College in Albany, New York on Saturday, October 13, and the Upper Hudson Valley walk on Saturday, October 6 at the Walkway Over the Hudson.
How Your Dollars Are Used
Research: Since its founding in 1949, LLS has invested more than $1 billion in lifesaving treatments, and more than $625 million of that has been raised through Light The Night.  LLS funded-research has led to key advances in understanding blood cancers and the lifesaving drugs to fight them.
Access: LLS provides a range of services, such as family support groups, an extensive educational web site, free seminars and conferences, and co-pay assistance. LLS has helped advance laws in 39 states to ensure coverage and payment parity for cancer medications, regardless of how or where they are administered.
Advancing Cures
Critical treatment innovations have originated through blood cancer research – radiation, chemotherapy, stem cell transplantation, and new targeted therapies. Nearly 40% of all FDA approved cancer drugs between 2000 and 2014 were first approved for blood cancer patients.  In 1964, the survival rate for children with the most commonly diagnosed leukemia was 3%; today it is approximately 90%. Since LLS’s inception, cures for many patients with acute lymphoblastic leukemia and Hodgkin lymphoma have been achieved.
The Facts:
  • Every 3 minutes someone is diagnosed with a blood cancer.
  • Every 9 minutes someone dies from a blood cancer.
  • Leukemia is the leading cause of cancer death in children and young adults under the age of 28.
  • Nearly 1.2 million people in the U.S. are living with, or are in remission from, a blood cancer.
  • In fiscal year 2017, LLS’s Co-Pay Assistance Program gave $65.9 million to more than 11,500 patients to help with their medical bills, including over $628,000 to 258 local families in our Chapter.